MY114109A - The use of bioassimilable boron compounds - Google Patents

The use of bioassimilable boron compounds

Info

Publication number
MY114109A
MY114109A MYPI95003541A MYPI19953541A MY114109A MY 114109 A MY114109 A MY 114109A MY PI95003541 A MYPI95003541 A MY PI95003541A MY PI19953541 A MYPI19953541 A MY PI19953541A MY 114109 A MY114109 A MY 114109A
Authority
MY
Malaysia
Prior art keywords
bioassimilable
boron compounds
subviral
combatting
subacute
Prior art date
Application number
MYPI95003541A
Inventor
Dr Eberhard Bengsch Prof
Dr Jurgen Polster Prof
Dr Antonius Kettrup Prof
Original Assignee
Gsf Forschungszentrum Fur Umwelt Und Gesungheit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Fur Umwelt Und Gesungheit filed Critical Gsf Forschungszentrum Fur Umwelt Und Gesungheit
Publication of MY114109A publication Critical patent/MY114109A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

THE INVENTION DISCLOSES THE USE OF BIOASSIMILABLE BORON COMPOUNDS FOR THE MANUFACTURE OF MEDICINES FOR COMBATTING SUBVIRAL PARTICLES WHICH, IN THE ANIMAL AND HUMAN AREAS, PRODUCE SUBACUTE , DEGENERATIVE, NON-INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM OR FOR THE PROTECTION FROM THE EFFECTS OF SUBVIRAL PATHOGENS IN PLANTS.
MYPI95003541A 1994-11-22 1995-11-20 The use of bioassimilable boron compounds MY114109A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4441483A DE4441483C1 (en) 1994-11-22 1994-11-22 Use of bio-assimilated boron cpds.

Publications (1)

Publication Number Publication Date
MY114109A true MY114109A (en) 2002-08-30

Family

ID=6533819

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI95003541A MY114109A (en) 1994-11-22 1995-11-20 The use of bioassimilable boron compounds

Country Status (8)

Country Link
EP (1) EP0797445B1 (en)
JP (1) JPH10509161A (en)
CN (1) CN1173135A (en)
AU (1) AU716511B2 (en)
DE (2) DE4441483C1 (en)
DK (1) DK0797445T3 (en)
MY (1) MY114109A (en)
WO (1) WO1996015798A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2399014A (en) * 2003-01-31 2004-09-08 Psimedica Ltd Device comprising resorbable silicon for boron neutron capture therapy
FR2870458B1 (en) 2004-05-24 2008-10-03 Centre Nat Rech Scient Cnrse PRODUCTS AND METHOD FOR DECONTAMINATION OF PRIONS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT180170B (en) * 1952-04-18 1954-11-10 Hans Schiefer Process for the manufacture of a preparation for the external treatment of infectious animal diseases
US4285934A (en) * 1979-07-13 1981-08-25 Tinnell James E Treatment for herpes virus
US4381296A (en) * 1980-06-23 1983-04-26 Tinnell James E Treatment for herpes virus
US4956385A (en) * 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
GB8706052D0 (en) * 1987-03-13 1987-04-15 Medical Research Int Therapeutic compositions
FR2625679B1 (en) * 1988-01-08 1990-02-09 Commin Alix AQUEOUS PREPARATION BASED ON MINERAL SALTS AND ACETIC ACID FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES
GB2215205A (en) * 1988-02-26 1989-09-20 Cyril Joseph France Skin treatment formulations comprising boric acid and/or perborate salt
US4963655A (en) * 1988-05-27 1990-10-16 Mayo Foundation For Medical Education And Research Boron analogs of amino acid/peptide protease inhibitors
US4936655A (en) * 1988-07-07 1990-06-26 Grumman Aerospace Corporation Alignment fixture for an optical instrument
DE3827340A1 (en) * 1988-08-12 1990-02-15 Hoechst Ag USE OF (ALPHA) -AMINOBORONIC ACID DERIVATIVES FOR THE PROPHYLAXIS AND TREATMENT OF VIRUS DISEASES
EP0502978A1 (en) * 1989-10-31 1992-09-16 Texas Cpr, Inc. Synthesis, composition and medical application of cyclic pentaborate compounds
WO1992001455A1 (en) * 1990-07-25 1992-02-06 Luedke Hans Werner Medicament against degenerative brain performance diseases of the alzheimer type and cholinergic system disturbances
FR2684002A1 (en) * 1991-11-26 1993-05-28 Duffaut Norbert Treatment of AIDS by means of aqueous compositions in which the base, which is unavoidable at the present time, consists, before potentiation, of organosilicon derivatives
CN1033683C (en) * 1992-11-11 1997-01-01 杨同华 Antiviral agent for crops

Also Published As

Publication number Publication date
AU4117196A (en) 1996-06-17
DE4441483C1 (en) 1996-04-04
WO1996015798A3 (en) 1996-08-08
DK0797445T3 (en) 2002-12-23
EP0797445A2 (en) 1997-10-01
JPH10509161A (en) 1998-09-08
EP0797445B1 (en) 2002-09-11
WO1996015798A2 (en) 1996-05-30
AU716511B2 (en) 2000-02-24
DE59510372D1 (en) 2002-10-17
CN1173135A (en) 1998-02-11

Similar Documents

Publication Publication Date Title
HUT75776A (en) Pyrazolo and pyrrolopyridines, their using, pharmaceutical compositions containing them and intermediates
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
BG63122B1 (en) Compounds and methods for cancer treatment
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
NZ332780A (en) Substituted amines for the treatment of neurological and neuropsychiatric disorders
TW200505483A (en) New medicament compositions based on anticholinergically-effective compounds and β-mimetics
MX9704037A (en) 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
NZ333232A (en) Use of p-aminophenol derivatives (paracetamol) to treat neurodegenerative disease
ATE240303T1 (en) 1,2,4-TRIAZOLE-3-THIONE COMPOUNDS
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
TR200100637T2 (en) New natural product derivatives
MX9704034A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof.
MY114109A (en) The use of bioassimilable boron compounds
AP2001002369A0 (en) Pharmaceutical complex.
AR015190A1 (en) A CRYSTALLINE POLYMORPH OF 1,3-DICICLOPROPILMETIL-8-AMINOXANTINA, PROCEDURE FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND ITS USING THE MANUFACTURE OF A MEDICINAL PRODUCT
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
US5547995B1 (en) Use of selegiline in veterinary medicine
MX9704035A (en) Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
PT986390E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCONHONINE CYCLORIDRATE
MX9704036A (en) 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
TR199901998T2 (en) Use of 9,10-secholesta-5,7,10(19)-triene-1,3-diol or alfacacidol.
HU9802142D0 (en) Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system
DE29509526U1 (en) Autoinjector for the treatment of asthmatic status